Clinical trial Recruiting at 1 site Interventional Ages 20 and up

Community participatory learning to prevent and control type 2 diabetes in rural Kabul

Official title: Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D-Afg]: Feasibility Trial in Rural Kabul-Afghanistan

Run by HealthNet Transcultural Psychosocial Organization · NCT07350694 · Data updated 2026-11-12

This project will try a community-led participatory learning and action program to prevent and control type 2 diabetes among adults living in rural Kabul.

Quick facts

Study typeInterventional
Ages20 Years and up
SexAll
Enrollment250 (estimated)
SponsorHealthNet Transcultural Psychosocial Organization
Academic / other
Locations1 site (Kabul, Kabul)
StatusRecruiting
StartedDecember 24, 2024
Main results expectedNovember 30, 2026
Study endsSeptember 30, 2027
Registry record updatedJanuary 20, 2026
Trial IDNCT07350694 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults living in the selected rural clusters of Kabul who are aged 20 years or older (and aged 30+ for baseline and endline assessments) who can attend meetings and give consent are eligible.

Probably not a fit

People under the age cutoffs, those unable or unwilling to attend regular meetings or give consent, or those with health conditions that prevent active participation are unlikely to benefit from the intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project adapts a Participatory Learning and Action (PLA) intervention proven in Bangladesh to the sociocultural and health system context of rural Kabul. Clusters in Kabul are randomized and adult community members will be invited to attend regular PLA group meetings led by local facilitators, with baseline and endline biomedical assessments. The intervention targets behaviors and community solutions to prevent progression from intermediate hyperglycaemia and to improve diabetes control, with outcomes compared between intervention and control clusters. Feasibility, acceptability, and preliminary changes in glycaemic measures and related risk factors will be measured.

Why it matters

Potential benefit: If successful, the approach could lower new cases of type 2 diabetes and improve glucose control in participating communities by changing behaviors and strengthening local support.

How similar studies have gone: A similar PLA intervention (the DMagic trial) showed effectiveness in rural Bangladesh, but PLA approaches have not previously been tested in rural Afghan communities.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* For intervention phase: Individuals aged 20 years and above. For baseline and endline assessments (before and after the intervention): Individuals aged 30 years and above.
* Participants residing in the randomized clusters of Kabul, Afghanistan Individuals willing to participate in the study and provide consent.
* All individuals with normoglycemia, intermediate hyperglycaemia, and diabetes are encouraged to participate.
* Participants who can attend the scheduled meetings and interventions as per the study protocol.

Exclusion Criteria:

* For Intervention phase: Individuals below the age of 20 years. For baseline and endline assessments (before and after the intervention): individuals below the age of 30 years.
* Individuals unwilling to provide consent for participation.
* Participants with reported health conditions that may hinder their active involvement in the study.
* Individuals with non-compliance with research protocols

Where it's running

  • HealthNet TPO, Afghanistan
    Kabul, Kabul, Afghanistan
    Recruiting

Study contacts

  • Principal investigator: Abdul Rahman Shahab, MPH — Deputy Country Director, HealthNet TPO, Afghanistan
  • Study coordinator: Abdul Rahman Shahab, MPH
  • Email: abdul.shahab@hntpo.org
  • Phone: +93786611325

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.